$KARX
Karbon-X Corp. Stock $karx

$karx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000147793223007813 Filed on October 23, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$36.08K	$3.758K	$0.00
YoY Change
Cost Of Revenue	$25.67K	$549.00	$0.00
YoY Change
Gross Profit	$10.41K	$3.209K	$0.00
YoY Change
Gross Profit Margin	28.85%	85.39%
Selling, General & Admin	$221.5K	$272.6K	$97.26K
YoY Change	97.2%	180.25%	1083.21%
% of Gross Profit	2127.47%	8493.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$540.00	$556.00	$229.00
YoY Change	80.0%	142.79%
% of Gross Profit	5.19%	17.33%
Operating Expenses	$304.1K	$325.5K	$195.9K
YoY Change	113.51%	66.17%	2282.82%
Operating Profit	-$293.7K	-$322.3K	-$195.9K
YoY Change	106.2%	64.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$3.070K	-$27.77K	$0.00
YoY Change	522.72%
Pretax Income	-$1.355M	-$350.0K	-$195.9K
YoY Change	854.6%	78.71%	2282.85%
Income Tax
% Of Pretax Income
Net Earnings	-$1.355M	-$350.0K	-$195.9K
YoY Change	854.6%	78.71%	2281.66%
Net Earnings / Revenue	-3754.96%	-9314.32%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	$0.00	-$2.844K
COMMON SHARES
Basic Shares Outstanding	78.55M shares		69.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$568.2K	$974.4K	$186.5K
YoY Change	889.6%	422.47%	58178.13%
Cash & Equivalents	$568.2K	$974.4K	$186.5K
Short-Term Investments
Other Short-Term Assets	$127.9K	$61.70K	$317.8K
YoY Change		-80.58%	1488.9%
Inventory
Prepaid Expenses		$61.70K	$317.8K
Receivables	$14.04K
Other Receivables	$23.91K
Total Short-Term Assets	$734.0K	$1.056M	$524.8K
YoY Change	779.51%	101.28%	2482.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$67.15K	$8.605K	$6.267K
YoY Change	1063.17%	37.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$2.464M
YoY Change	-100.0%
Other Assets	$179.1K	$146.7K	$87.35K
YoY Change	114.49%	67.91%
Total Long-Term Assets	$769.9K	$3.208M	$93.62K
YoY Change	-50.87%	3327.09%
TOTAL ASSETS
Total Short-Term Assets	$734.0K	$1.056M	$524.8K
Total Long-Term Assets	$769.9K	$3.208M	$93.62K
Total Assets	$1.504M	$4.265M	$618.4K
YoY Change	-8.88%	589.59%	2943.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.25K	$29.91K	$3.570K
YoY Change	-59.79%	737.73%	-44.74%
Accrued Expenses	$52.23K	$46.89K	$3.070K
YoY Change	1035.43%	1427.36%
Deferred Revenue
YoY Change
Short-Term Debt	$2.280K	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$278.7K	$272.2K	$6.640K
YoY Change	260.31%	3998.92%	-92.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$43.76K	$49.83K	$0.00
YoY Change
Total Long-Term Liabilities	$43.76K	$49.83K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$278.7K	$272.2K	$6.640K
Total Long-Term Liabilities	$43.76K	$49.83K	$0.00
Total Liabilities	$322.4K	$322.0K	$6.641K
YoY Change	316.88%	4748.59%	-92.92%
SHAREHOLDERS EQUITY
Retained Earnings		-$2.542M	-$400.1K
YoY Change		535.38%	333.16%
Common Stock		$78.55K	$69.04K
YoY Change		13.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.181M	$3.943M	$611.8K
YoY Change
Total Liabilities & Shareholders Equity	$1.504M	$4.265M	$618.4K
YoY Change	-8.88%	589.59%	2943.44%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.355M	-$350.0K	-$195.9K
YoY Change	854.6%	78.71%	2281.66%
Depreciation, Depletion And Amortization	$540.00	$556.00	$229.00
YoY Change	80.0%	142.79%
Cash From Operating Activities	-$403.9K	-$180.3K	-$457.4K
YoY Change	-688.22%	-60.59%	1524540.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$3.243K
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	-$602.4K
YoY Change
Cash From Investing Activities	-$100.0K	-$602.4K	-$3.243K
YoY Change	-43.18%	18475.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.556M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	110.0K	$1.556M	$180.0K
YoY Change		764.26%
NET CHANGE
Cash From Operating Activities	-403.9K	-$180.3K	-$457.4K
Cash From Investing Activities	-100.0K	-$602.4K	-$3.243K
Cash From Financing Activities	110.0K	$1.556M	$180.0K
Net Change In Cash	-393.9K	$767.5K	-$290.9K
YoY Change	267.01%	-363.89%	969406.67%
FREE CASH FLOW
Cash From Operating Activities	-$403.9K	-$180.3K	-$457.4K
Capital Expenditures	$0.00	$0.00	$3.243K
Free Cash Flow	-$403.9K	-$180.3K	-$460.6K
YoY Change	276.32%	-60.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8605	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	29907	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	69732	usd
CY2023Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	20308	usd
CY2023Q3	us-gaap	Investments Investments	2464203	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	3209	usd
CY2022Q3	us-gaap	Marketing Expense MarketingExpense	10664	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	78291	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	86595	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1056361	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63924	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	68307	usd
CY2023Q3	us-gaap	Other Inventory OtherInventory	139121	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	100000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78553858	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72579000	shares
CY2023Q3	us-gaap	Revenues Revenues	3758	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	172887	usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages	0	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	325474	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	195868	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-322265	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-195868	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27767	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	637870	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2265219	usd
CY2023Q3	karx	Shares To Be Issued For Investment SharesToBeIssuedForInvestment	375000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206820	usd
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001729637
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78553858	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72579000	shares
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-08-31
CY2023Q3	dei	Entity File Number EntityFileNumber	000-56288
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	KARBON-X CORP.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-2882342
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	910 7th Ave SW
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Calgary
CY2023Q3	dei	Entity Address Country EntityAddressCountry	CA
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	T2P 3N8
CY2023Q3	dei	City Area Code CityAreaCode	778
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	256-5730
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78553858	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	974356	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	206820	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61697	usd
CY2023Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	524871	usd
CY2023Q2	us-gaap	Other Inventory OtherInventory	80750	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22376	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14688	usd
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	195372	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q3	us-gaap	Liabilities Liabilities	321995	usd
CY2023Q2	us-gaap	Liabilities Liabilities	249896	usd
CY2023Q3	karx	Shares To Be Issued SharesToBeIssued	1500000	usd
CY2023Q2	karx	Shares To Be Issued SharesToBeIssued	1750000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4913228	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2638532	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2542138	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2192106	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7009	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3786	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3942635	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2265219	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4264630	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2515115	usd
CY2022Q3	us-gaap	Revenues Revenues	0	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	549	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	0	usd
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	21395	usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses	52901	usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses	98609	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-350032	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-195868	usd
CY2023Q3	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2022Q3	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-350032	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-195868	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3223	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10217	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-353255	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-206085	usd
CY2023Q3	karx	Weighted Average Basic And Diluted Shares Outstanding WeightedAverageBasicAndDilutedSharesOutstanding	75895837	shares
CY2022Q3	karx	Weighted Average Basic And Diluted Shares Outstanding WeightedAverageBasicAndDilutedSharesOutstanding	68882637	shares
CY2023Q3	karx	Earnings Per Share Basic And Fully Diluted EarningsPerShareBasicAndFullyDiluted	-0.00
CY2022Q3	karx	Earnings Per Share Basic And Fully Diluted EarningsPerShareBasicAndFullyDiluted	-0.00
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	180000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10217	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-195868	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	611784	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1555671	usd
CY2023Q3	karx	Conversion Of Loan To Shares Amount ConversionOfLoanToSharesAmount	100000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3223	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-350032	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	3942635	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-350032	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-195868	usd
CY2023Q3	us-gaap	Depreciation Depreciation	556	usd
CY2022Q3	us-gaap	Depreciation Depreciation	229	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	27687	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4727	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2023Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	25278	usd
CY2022Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-9732	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-39826	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27184	usd
CY2023Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	14452	usd
CY2022Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	95	usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	195372	usd
CY2022Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-58371	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-86000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1930	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-138198	usd
CY2023Q3	karx	Increase Decrease In Payments Made On Operating Lease IncreaseDecreaseInPaymentsMadeOnOperatingLease	1812	usd
CY2022Q3	karx	Increase Decrease In Payments Made On Operating Lease IncreaseDecreaseInPaymentsMadeOnOperatingLease	0	usd
CY2023Q3	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	0	usd
CY2022Q3	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-735	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-180276	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-184587	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3242	usd
CY2023Q3	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	602407	usd
CY2022Q3	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-602407	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3242	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1555671	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	180000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1555671	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	180000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5452	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10217	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	767536	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-290851	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	974356	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186488	usd
CY2023Q3	karx	Non Cash Depreciation Expense NonCashDepreciationExpense	556	usd
CY2022Q3	karx	Non Cash Depreciation Expense NonCashDepreciationExpense	229	usd
CY2023Q3	karx	Non Cash Loss On Investment NonCashLossOnInvestment	27687	usd
CY2022Q3	karx	Non Cash Loss On Investment NonCashLossOnInvestment	0	usd
CY2023Q3	karx	Non Cash Amortization Of Right Of Use Asset NonCashAmortizationOfRightOfUseAsset	4727	usd
CY2022Q3	karx	Non Cash Amortization Of Right Of Use Asset NonCashAmortizationOfRightOfUseAsset	0	usd
CY2023Q3	karx	Shares To Be Issued For The Silviculture Investment SharesToBeIssuedForTheSilvicultureInvestment	375000	usd
CY2022Q3	karx	Shares To Be Issued For The Silviculture Investment SharesToBeIssuedForTheSilvicultureInvestment	0	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q3	karx	Issued And Outstanding Shares Of Common Stock Converted Exchange Ratio Description IssuedAndOutstandingSharesOfCommonStockConvertedExchangeRatioDescription	20,000-for-1
CY2023Q3	karx	Shares Authorized SharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	134	usd
CY2023Q3	karx	Related Party Transaction Amounts Due From To Related Party RelatedPartyTransactionAmountsDueFromToRelatedParty	99902	usd
CY2023Q3	us-gaap	Other Operating Income OtherOperatingIncome	2542138	usd
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. </p>
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2023Q3	karx	Weighted Average Remaining Contractual Life In Years Beginning Balance WeightedAverageRemainingContractualLifeInYearsBeginningBalance	P0Y6M29D
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10400	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.50
CY2023Q3	karx	Weighted Average Remaining Contractual Life In Years Granted WeightedAverageRemainingContractualLifeInYearsGranted	P1Y11M1D
CY2023Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;font-family:times new roman;margin:0px">Certain amounts in the consolidated financial statements for the prior year have been reclassified to conform to the current year presentation. These reclassifications had no impact on net earnings, financial position, or cash flows.</p>
CY2023Q3	karx	Prepaid Transfer Agent Fees Current PrepaidTransferAgentFeesCurrent	1690	usd
CY2023Q2	karx	Prepaid Transfer Agent Fees Current PrepaidTransferAgentFeesCurrent	0	usd
CY2023Q3	karx	Prepaid Inventory Current PrepaidInventoryCurrent	60007	usd
CY2023Q2	karx	Prepaid Inventory Current PrepaidInventoryCurrent	59767	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	61697	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	59767	usd
CY2023Q3	karx	Carbon Credit Inventory Amount CarbonCreditInventoryAmount	139121	usd
CY2023Q2	karx	Carbon Credit Inventory Amount CarbonCreditInventoryAmount	80750	usd
CY2023Q3	us-gaap	Other Inventory OtherInventory	139121	usd
CY2023Q2	us-gaap	Other Inventory OtherInventory	80750	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4150400	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.75
CY2023Q3	karx	Weighted Average Remaining Contractual Life In Years Ending Balance WeightedAverageRemainingContractualLifeInYearsEndingBalance	P0Y8M4D
CY2023Q3	karx	Weighted Average Remaining Lease Term Years WeightedAverageRemainingLeaseTermYears	P2Y11M1D
CY2023	karx	Office Chairs Purchase OfficeChairsPurchase	6607	usd
CY2023	karx	Computers Purchase ComputersPurchase	3705	usd
CY2023Q3	us-gaap	Depreciation Depreciation	556	usd
CY2022Q3	us-gaap	Depreciation Depreciation	229	usd
CY2023Q3	karx	Statement Of Stockholders Equity StatementOfStockholdersEquity	the Company executed an agreement to issue shares of Karbon-X Corp for the purchase of up to 80% of Silviculture Systems to be issued in tranches based on completion of milestones. During the three months ended August 31, 2023, the Company issued 1,500,000 shares of Karbon-X Corp for the purchase of an additional 8% of Silviculture Systems shown as shares to be issued at a value of $375,000. As of August 31, 2023, the Company has purchased 32% of Silviculture Systems for 6,000,000 shares of Karbon-X Corp shown as shares to be issued for a value of $1,500,000
CY2023Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.50
CY2023Q3	karx	Warrants Issued WarrantsIssued	10400	shares
CY2023Q3	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.50
CY2023Q3	karx	Value Of Warrants ValueOfWarrants	2236	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4140000	shares
CY2023Q2	karx	Share Exchange Agreement ShareExchangeAgreement	0.80	pure
CY2023Q2	karx	Share Exchange Agreement Value ShareExchangeAgreementValue	7250000	usd
CY2023Q3	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	524871	usd
CY2022Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	522771	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	100000	usd
CY2023Q3	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.08	pure
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	200000	shares
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2023Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	6583	usd
CY2022Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4809	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	21558	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	28745	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	28745	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4791	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	83839	usd
CY2023Q3	karx	Less Imputed Interest LessImputedInterest	-11636	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	72203	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22376	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	49827	usd
CY2023Q3	us-gaap	Financial Guarantee Insurance Contracts Claim Liability Weighted Average Risk Free Discount Rate FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate	0.1025	pure

Files In Submission

Name	View Source	Status
0001477932-23-007813-index-headers.html	Edgar Link	pending
0001477932-23-007813-index.html	Edgar Link	pending
0001477932-23-007813.txt	Edgar Link	pending
0001477932-23-007813-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
karx-20230831.xsd	Edgar Link	pending
karx_10q.htm	Edgar Link	pending
karx_ex311.htm	Edgar Link	pending
karx_ex312.htm	Edgar Link	pending
karx_ex321.htm	Edgar Link	pending
karx_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
karx-20230831_cal.xml	Edgar Link	unprocessable
karx-20230831_def.xml	Edgar Link	unprocessable
karx-20230831_lab.xml	Edgar Link	unprocessable
karx-20230831_pre.xml	Edgar Link	unprocessable
karx_10q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KARX
Karbon-X Corp. Stock $karx

2023 Q4 Form 10-Q Financial Statement

#000147793223007813 Filed on October 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KARX Karbon-X Corp. Stock $karx

2023 Q4 Form 10-Q Financial Statement

#000147793223007813 Filed on October 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KARX
Karbon-X Corp. Stock $karx